Guanine Inc

Description

• UNIVERSAL BIOANALYTE AMPLIFICATION: Guanines proprietary technology amplifies and quantifies microbes including specific microbe strains, associated protein toxins, and drug resistant biomarkers, without enrichment or PCR using a rapid, simple and inexpensive platform. Patent pending innovation includes: Amplification of bioanalytes using amplification microbeads that replace optical labels with millions of electrochemically quantifiable tags per bioanalyte Quantification of electrochemically tags with an electrochemical biosensor Multiplex quantification using and bioanalyte-specific tags and bioanalyte-specific working electrodes Rapid, simple and inexpensive test cycle that can be used for research applications in kits, or assays in POC cartridges, high throughput panels, and autonomous sensor stations FOCUS ON DIFFICULT-TO-DETECT BACTERIA: Although its universal bioanalyte amplification technology can be used in numerous applications, Guanine is predominantly focused on providing products, services and licenses for difficult-to-detect bacteria including multi-drug resistant organisms, hospital-acquired infection bacteria, microbiome organisms, biothreat agents and virulent food and environmental pathogens. CONTACT: Neil.Gordon@GuanineInc.com
• 

  Headquarters:7 University Place Suite B210, Rensselaer, New York, United States

  More
• 

  Phone Number: +1 801-792-7074

• 

  Website: https://www.guanineinc.com

• 

  Employees:4

• 

  Revenue:$1 - 10M

• 

  Legal Name:Guanine Inc

• Guanine Inc's Social Media

  
• Is this data correct?

• |  NAICS Code: 325412  |

  Show More